Pharmabiz1d
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
Contract Pharma1d
GSK Acquires IDRx
GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...
GSK completes acquisition of IDRx
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
PharmiWeb1d
GSK completes acquisition of IDRx, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...
GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback
GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.